Finerenone and Clinical Outcomes in CKD and Type 2 Diabetes by Frailty Index
Finerenone and Clinical Outcomes in CKD and Type 2 Diabetes by Frailty Index is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Finerenone and Clinical Outcomes in CKD and Type 2 Diabetes by Frailty Index have?
Finerenone and Clinical Outcomes in CKD and Type 2 Diabetes by Frailty Index has 2 citations in the OpenAlex counts ScholarIQ stores.
When was Finerenone and Clinical Outcomes in CKD and Type 2 Diabetes by Frailty Index published?
Finerenone and Clinical Outcomes in CKD and Type 2 Diabetes by Frailty Index has 2025 year in the ScholarIQ index.
What is the open-access status of Finerenone and Clinical Outcomes in CKD and Type 2 Diabetes by Frailty Index?
Finerenone and Clinical Outcomes in CKD and Type 2 Diabetes by Frailty Index has hybrid oa status in the ScholarIQ index.
What is the DOI of Finerenone and Clinical Outcomes in CKD and Type 2 Diabetes by Frailty Index?
The DOI for Finerenone and Clinical Outcomes in CKD and Type 2 Diabetes by Frailty Index is on the source record.
What is the PMID of Finerenone and Clinical Outcomes in CKD and Type 2 Diabetes by Frailty Index?
The PMID for Finerenone and Clinical Outcomes in CKD and Type 2 Diabetes by Frailty Index is on the source record.
What is the OpenAlex record for Finerenone and Clinical Outcomes in CKD and Type 2 Diabetes by Frailty Index?
The OpenAlex for Finerenone and Clinical Outcomes in CKD and Type 2 Diabetes by Frailty Index is on the source record.